Skip to content

Author

T. Alandijany

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Respiratory syncytial virus (RSV) in Saudi Arabian children: Epidemiological burden, seasonality, and the evolving landscape of prevention.

Respiratory syncytial virus (RSV) is a major cause of pediatric respiratory disease in Saudi Arabia, particularly among infants during the first six months of life. Saudi studies report RSV detection in approximately 20-26% of hospitalized children with respiratory illness, although estimates vary by population, settin...

Ammar A. Basabrain, Alaa M. Alkinani, Nedaa A. Alabdali et al. · 0 citations
Review Open access Sep 2026

Mechanisms and applications of camelid variable heavy-chain nanobodies against bacterial and parasitic protozoal pathogens

Camelid variable heavy-chain (VHH) nanobodies have emerged as a promising class of single-domain antibodies with significant potential for combating bacterial and parasitic infections. Their small molecular size, high solubility, exceptional physicochemical stability, and ability to recognize cryptic or conformational...

H. Gattan, T. Alandijany · 0 citations
#protein folding Review Open access Oct 2026

ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development

Abstract Hepatitis E virus (HEV) causes over 19 million infections annually, yet the molecular determinants governing its diverse clinical phenotypes and cross-genotype immunity remain incompletely synthesized. The ORF2 capsid protein is the sole structural component of the virion, the primary neutralizing antibody tar...

Shreif A. El-Kafrawy, S. S. Putra, A. Abbas et al. · 0 citations
Review Open access Sep 2026

Camelid VHHs as a Versatile Platform for Combating Viral Infections

The available evidence indicates that camelid VHH represent a highly versatile and adaptable platform for antiviral therapeutics and diagnostics, with considerable potential to support pandemic preparedness and the development of broad-spectrum interventions against current and emerging viral diseases.

M. Mufrrih, T. Alandijany · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.